These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21247354)

  • 1. The Waters Bioanalysis World Tour: insights into the next decade of regulated bioanalysis.
    De Vooght-Johnson R
    Bioanalysis; 2011 Feb; 3(4):369-82. PubMed ID: 21247354
    [No Abstract]   [Full Text] [Related]  

  • 2. 5th Bioanalysis in Clinical Research.
    Zhou M
    Bioanalysis; 2010 Jun; 2(6):999-1003. PubMed ID: 21083202
    [No Abstract]   [Full Text] [Related]  

  • 3. The broadening scope of validation: towards best practices in the world of bioanalysis.
    Abbott RW
    Bioanalysis; 2010 Apr; 2(4):703-8. PubMed ID: 21083266
    [No Abstract]   [Full Text] [Related]  

  • 4. Analytical chemistry for drug discovery and development.
    Roda A
    Anal Bioanal Chem; 2010 Sep; 398(1):27-8. PubMed ID: 20652554
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and pharmaceutical success from discovery to regulatory approval: biomarkers, modeling and analytical technologies.
    Zhang TT; Weng N; Lee M
    Bioanalysis; 2017 Oct; 9(19):1437-1440. PubMed ID: 29057664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug bioanalysis and biomarker discovery at the Commissariat à l'énergie atomique et aux énergies alternatives.
    Ezan E; Becher F; Benech H; Fenaille F; Junot C; Mabondzo A; Pruvost A
    Bioanalysis; 2010 Apr; 2(4):713-7. PubMed ID: 21083268
    [No Abstract]   [Full Text] [Related]  

  • 7. European Bioanalysis Forum and the way forward towards harmonized regulations.
    Lausecker B; van Amsterdam P; Brudny-Kloeppel M; Luedtke S; Timmerman P
    Bioanalysis; 2009 Aug; 1(5):873-5. PubMed ID: 21083056
    [No Abstract]   [Full Text] [Related]  

  • 8. Application and interpretation of free and total drug measurements in the development of biologics.
    Ahene AB
    Bioanalysis; 2011 Jun; 3(11):1287-95. PubMed ID: 21649503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceuticals and related drugs.
    Gilpin RK; Gilpin CS
    Anal Chem; 2007 Jun; 79(12):4275-93. PubMed ID: 17511425
    [No Abstract]   [Full Text] [Related]  

  • 10. Recommendations on ISR in multi analyte assays, QA/bioanalytical consultants and GCP by Global CRO Council for Bioanalysis (GCC).
    Sangster T; Maltas J; Struwe P; Hillier J; Boterman M; Doig M; Breda M; Garofolo F; Caturla MC; Couerbe P; Schiebl C; Pattison C; Goodwin L; Segers R; Garofolo W; Folguera L; Zimmer D; Zimmerman T; Pawula M; Tang D; Cox C; Bigogno C; Schoutsen D; de Boer T; Green R; Houghton R; Sable R; Siethoff C; Harter T; Best S;
    Bioanalysis; 2012 Jul; 4(14):1723-30. PubMed ID: 22877218
    [No Abstract]   [Full Text] [Related]  

  • 11. Symposium report: the Waters Bioanalysis World Tour: the broadening impact and future of the DMPK laboratory--addressing large-molecule therapeutics.
    De Vooght-Johnson R
    Bioanalysis; 2011 Mar; 3(6):579-91. PubMed ID: 21391863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2009 White Paper on recent issues in regulated bioanalysis from the 3rd Calibration and Validation Group Workshop.
    Savoie N; Garofolo F; van Amsterdam P; Booth BP; Fast DM; Lindsay M; Lowes S; Masse R; Mawer L; Ormsby E; Phull R; Rocci ML; Vallano PT; Yin X
    Bioanalysis; 2010 Jan; 2(1):53-68. PubMed ID: 21083120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerating Regulated Bioanalysis for Biotherapeutics: Case Examples Using a Microfluidic Ligand Binding Assay Platform.
    Liu R; Hoffpauir B; Chilewski SD; Gamberdella J; Kavita U; Duo J; Gleason C; Zhang Y; Pillutla R; DeSilva B; Hamuro L
    AAPS J; 2017 Jan; 19(1):82-91. PubMed ID: 27796911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symposium report: the Waters Bioanalysis World Tour.
    De Vooght-Johnson R
    Bioanalysis; 2010 Dec; 2(12):1931-42. PubMed ID: 21110737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control and analysis of hydrazine, hydrazides and hydrazones--genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products.
    Elder DP; Snodin D; Teasdale A
    J Pharm Biomed Anal; 2011 Apr; 54(5):900-10. PubMed ID: 21145684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conference report: Inaugural Applied Pharmaceutical Analysis: India 2010 conference.
    Ramanathan R; Chaudhary A
    Bioanalysis; 2010 Jul; 2(7):1181-4. PubMed ID: 21083232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conference report: European Bioanalysis Forum.
    Abbott RW; Brudny-Kloeppel M
    Bioanalysis; 2009 May; 1(2):273-6. PubMed ID: 21083164
    [No Abstract]   [Full Text] [Related]  

  • 18. 2010 white paper on recent issues in regulated bioanalysis & global harmonization of bioanalytical guidance.
    Savoie N; Garofolo F; van Amsterdam P; Bansal S; Beaver C; Bedford P; Booth BP; Evans C; Jemal M; Lefebvre M; Lopes de Silva AL; Lowes S; Marini JC; Massé R; Mawer L; Ormsby E; Rocci ML; Viswanathan C; Wakelin-Smith J; Welink J; White JT; Woolf E
    Bioanalysis; 2010 Dec; 2(12):1945-60. PubMed ID: 21110739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioanalysis and Analytical Services Research Group at The Municipal Institute for Medical Research IMIM-Hospital del Mar, Spain.
    Segura J; Pascual JA; Ventura R; Gutiérrez-Gallego R
    Bioanalysis; 2009 Nov; 1(8):1403-9. PubMed ID: 21083089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sponsor relationships, analyte stability in ligand-binding assays and critical reagent management: a bioanalytical CRO perspective.
    Lefor Bradford J
    Bioanalysis; 2015; 7(11):1337-46. PubMed ID: 26110706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.